TrialJournal of autism and developmental disorders2014
STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study.
Craig A Erickson et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
74 papers cite itlatest 60 shown
this paperpooled ittrialcites it